SCHEMBL16367346

SCHEMBL16367346

CC(=O)OC(COS(=O)(=O)c1ccc(C)cc1)C(Cn1cnc([N+](=O)[O-])c1)OC(C)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 3/20 0.35
PKM P14618 2/20 0.35
TAAR1 Q96RJ0 1/20 0.34
KMT2A Q03164 2/20 0.34
HTT P42858 2/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
EGFR P00533 1/20 0.32
ERBB2 P04626 1/20 0.32
DHODH Q02127 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16367345 0.89 L3MBTL1 (0.38) L3MBTL1ALDH1A1PKMTAAR1KMT2A
SCHEMBL16367336 0.86 L3MBTL1 (0.38) L3MBTL1ALDH1A1PKMTAAR1KMT2A
SCHEMBL16367389 0.84 ALDH1A1 (0.39) L3MBTL1ALDH1A1PKMTAAR1KMT2A
SCHEMBL16367390 0.83 L3MBTL1 (0.38) L3MBTL1ALDH1A1PKMTAAR1KMT2A
SCHEMBL16367360 0.79 L3MBTL1 (0.43) L3MBTL1ALDH1A1PKMTAAR1KMT2A
SCHEMBL16367343 0.79 EGFR (0.36) ALDH1A1PKMSMN1; SMN2LMNAMAPK1
SCHEMBL8424432 0.78 DHODH (0.44) ALDH1A1PKMKMT2AGAALMNA
SCHEMBL16367348 0.77 DHODH (0.34) ALDH1A1PKMKMT2AMEN1MAPT
SCHEMBL11867519 0.76 PKM (0.41) L3MBTL1ALDH1A1PKMTAAR1HTT
SCHEMBL15544602 0.75 PKM (0.35) L3MBTL1ALDH1A1PKMTAAR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150010474-A1 Compounds And Methods For Selective Imaging And/Or Ablation AUCKLAND UNISERVICES LTD (NL) 2015-01-08 US disclosed
US-20150010474-A1 Compounds And Methods For Selective Imaging And/Or Ablation AUCKLAND UNISERVICES LTD (NL) 2015-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150010474-A1 Compounds And Methods For Selective Imaging And/Or Ablation CBR1, CBR3, BLVRB L3MBTL1 2029/4885ALDH1A1 140/4885PKM 867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.